Oxidative stress-mediated inhibition of brain creatine kinase activity by methylmercury

NeuroToxicology

Volumn 31, Issue 5, 2010, Pages 454-460

  Glaser, Viviane ^a   Leipnitz, Guilhian ^b   Straliotto, Marcos Raniel ^a   Oliveira, Jade ^a   dos Santos, Vanessa Valgas ^a   Wannmacher, Clóvis Milton Duval ^b   de Bem, Andreza Fabro ^a   Rocha, João Batista Teixeira ^c   Farina, Marcelo ^a   Latini, Alexandra ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

Author keywords

Creatine kinase; Methylmercury; Neurotoxicity

Indexed keywords

CARBONYL DERIVATIVE; CREATINE KINASE; METHYLMERCURY; REACTIVE OXYGEN METABOLITE; THIOL;

AEROBIC METABOLISM; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN MITOCHONDRION; CELL ENERGY; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENERGY METABOLISM; ENZYME INHIBITION; GLIOMA CELL; MALE; MOUSE; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL;

EID: 84984549114     PISSN: 0161813X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuro.2010.05.012     Document Type: Article

References (67)

1. Adachi T., Kunimoto M. Acute cytotoxic effects of mercuric compounds in cultured astrocytes prepared from cerebral hemisphere and cerebellum of newborn rats. Biol Pharm Bull 2005, 28:2308-2311.
2. Adams V., Bosch W., Schlegel J., Wallimann T., Brdiczka D. Further characterization of contact sites from mitochondria of different tissues: topology of peripheral kinases. Biochim Biophys Acta 1989, 981:213-225.
3. Aksenov M., Aksenova M., Butterfield D.A., Markesbery W.R. Oxidative modification of creatine kinase BB in Alzheimer's disease brain. J Neurochem 2000, 74:2520-2527.
4. Almeida A., Almeida J., Bolanos J.P., Moncada S. Different responses of astrocytes and neurons to nitric oxide: the role of glycolytically generated ATP in astrocyte protection. Proc Natl Acad Sci USA 2001, 98:15294-15299.
5. Andrienko T., Kuznetsov A.V., Kaambre T., Usson Y., Orosco A., Appaix F., et al. Metabolic consequences of functional complexes of mitochondria, myofibrils and sarcoplasmic reticulum in muscle cells. J Exp Biol 2003, 206:2059-2072.
6. Aschner M., Clarkson T.W. Uptake of methylmercury in the rat brain: effects of amino acids. Brain Res 1988, 462:31-39.
7. Aschner M., Syversen T., Souza D.O., Rocha J.B., Farina M. Involvement of glutamate and reactive oxygen species in methylmercury neurotoxicity. Braz J Med Biol Res 2007, 40:285-291.
8. Atchison W.D., Hare M.F. Mechanisms of methylmercury-induced neurotoxicity. FASEB J 1994, 8:622-629.
9. Bakir F., Damluji S.F., Amin-Zaki L., Murtadha M., Khalidi A., al-Rawi N.Y., et al. Methylmercury poisoning in Iraq. Science 1973, 181:230-241.
10. Beal M.F. Energetics in the pathogenesis of neurodegenerative diseases. Trends Neurosci 2000, 23:298-304.
11. Beal M.F. Coenzyme Q10 as a possible treatment for neurodegenerative diseases. Free Radical Res 2002, 36:455-460.
12. Beutner G., Ruck A., Riede B., Brdiczka D. Complexes between porin, hexokinase, mitochondrial creatine kinase and adenylate translocator display properties of the permeability transition pore. Implication for regulation of permeability transition by the kinases. Biochim Biophys Acta 1998, 1368:7-18.
13. Carvalho M.C., Franco J.L., Ghizoni H., Kobus K., Nazari E.M., Rocha J.B., et al. Effects of 2,3-dimercapto-1-propanesulfonic acid (DMPS) on methylmercury-induced locomotor deficits and cerebellar toxicity in mice. Toxicology 2007, 239:195-203.
14. Choi B.H. The effects of methylmercury on the developing brain. Prog Neurobiol 1989, 32:447-470.
15. Clarkson T.W., Magos L. The toxicology of mercury and its chemical compounds. Crit Rev Toxicol 2006, 36:609-662.
16. Clarkson T.W., Magos L., Myers G.J. The toxicology of mercury-current exposures and clinical manifestations. N Engl J Med 2003, 349:1731-1737.
17. Cooper A.J., Kristal B.S. Multiple roles of glutathione in the central nervous system. Biol Chem 1997, 378:793-802.
18. Crozatier B., Badoual T., Boehm E., Ennezat P.V., Guenoun T., Su J., et al. Role of creatine kinase in cardiac excitation-contraction coupling: studies in creatine kinase-deficient mice. FASEB J 2002, 16:653-660.
19. Dave V., Mullaney K.J., Goderie S., Kimelberg H.K., Aschner M. Astrocytes as mediators of methylmercury neurotoxicity: effects on d-aspartate and serotonin uptake. Dev Neurosci 1994, 16:222-231.
20. Dietrich M.O., Mantese C.E., dos Anjos G., Souza D.O., Farina M. Motor impairment induced by oral exposure to methylmercury in adult mice. Environ Toxicol Pharmacol 2005, 19:169-175.
21. Dixon M., Webb E.C. Enzymes 1964, Longmans, London.
22. Dolder M., Walzel B., Speer O., Schlattner U., Wallimann T. Inhibition of the mitochondrial permeability transition by creatine kinase substrates. Requirement for microcompartmentation. J Biol Chem 2003, 278:17760-17766.
23. dos Santos A.Q., Nardin P., Funchal C., de Almeida L.M., Jacques-Silva M.C., Wofchuk S.T., et al. Resveratrol increases glutamate uptake and glutamine synthetase activity in C6 glioma cells. Arch Biochem Biophys 2006, 453:161-167.
24. Dringen R., Hirrlinger J. Glutathione pathways in the brain. Biol Chem 2003, 384:505-516.
25. Ellman G.L. Tissue sulfhydryl groups. Arch Biochem Biophys 1959, 82:70-77.
26. Farina M., Franco J.L., Ribas C.M., Meotti F.C., Missau F.C., Pizzolatti M.G., et al. Protective effects of Polygala paniculata extract against methylmercury-induced neurotoxicity in mice. J Pharm Pharmacol 2005, 57:1503-1508.
27. Farina M., Campos F., Vendrell I., Berenguer J., Barzi M., Pons S., et al. Probucol increases glutathione peroxidase-1 activity and displays long-lasting protection against methylmercury toxicity in cerebellar granule cells. Toxicol Sci 2009, 112:416-426.
28. Ferrante R.J., Andreassen O.A., Jenkins B.G., Dedeoglu A., Kuemmerle S., Kubilus J.K., et al. Neuroprotective effects of creatine in a transgenic mouse model of Huntington's disease. J Neurosci 2000, 20:4389-4397.
29. Franco J.L., Braga Hde C., Nunes A.K., Ribas C.M., Stringari J., Silva A.P., et al. Lactational exposure to inorganic mercury: evidence of neurotoxic effects. Neurotoxicol Teratol 2007, 29:360-367.
30. Franco J.L., Posser T., Dunkley P.R., Dickson P.W., Mattos J.J., Martins R., et al. Methylmercury neurotoxicity is associated with inhibition of the antioxidant enzyme glutathione peroxidase. Free Radical Biol Med 2009, 47:449-457.
31. Grandjean P., Weihe P., White R.F., Debes F., Araki S., Yokoyama K., et al. Cognitive deficit in 7-year-old children with prenatal exposure to methylmercury. Neurotoxicol Teratol 1997, 19:417-428.
32. Hamada R., Osame M. Minamata disease and other mercury syndromes. Toxicology of metals 1996, 337-351. CRC Press, Boca Raton. L.W. Chang (Ed.).
33. Hemmer W., Wallimann T. Functional aspects of creatine kinase in brain. Dev Neurosci 1993, 15:249-260.
34. Hughes B.P. A method for the estimation of serum creatine kinase and its use in comparing creatine kinase and aldolase activity in normal and pathological sera. Clin Chim Acta 1962, 7:597-603.
35. Hunter D., Russell D.S. Focal cerebellar and cerebellar atrophy in a human subject due to organic mercury compounds. J Neurol Neurosurg Psychiatry 1954, 17:235-241.
36. Janssen E., Terzic A., Wieringa B., Dzeja P.P. Impaired intracellular energetic communication in muscles from creatine kinase and adenylate kinase (M-CK/AK1) double knock-out mice. J Biol Chem 2003, 278:30441-30449.
37. Kaur P., Aschner M., Syversen T. Role of glutathione in determining the differential sensitivity between the cortical and cerebellar regions towards mercury-induced oxidative stress. Toxicology 2007, 230:164-177.
38. Kenyon G.L. Energy metabolism. Creatine kinase shapes up. Nature 1996, 381:281-282.
39. Konorev E.A., Hogg N., Kalyanaraman B. Rapid and irreversible inhibition of creatine kinase by peroxynitrite. FEBS Lett 1998, 427:171-174.
40. Koufen P., Stark G. Free radical induced inactivation of creatine kinase: sites of interaction, protection, and recovery. Biochim Biophys Acta 2000, 1501:44-50.
41. Latini A., da Silva C.G., Ferreira G.C., Schuck P.F., Scussiato K., Sarkis J.J., et al. Mitochondrial energy metabolism is markedly impaired by d-2-hydroxyglutaric acid in rat tissues. Mol Genet Metab 2005, 86:188-199.
42. Leuzzi V. Inborn errors of creatine metabolism and epilepsy: clinical features, diagnosis, and treatment. J Child Neurol 2002, 17. 3S89-97, discussion 83S97.
43. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem 1951, 193:265-275.
44. Manfroi C.B., Schwalm F.D., Cereser V., Abreu F., Oliveira A., Bizarro L., et al. Maternal milk as methylmercury source for suckling mice: neurotoxic effects involved with the cerebellar glutamatergic system. Toxicol Sci 2004, 81:172-178.
45. Mori N., Yasutake A., Hirayama K. Comparative study of activities in reactive oxygen species production/defense system in mitochondria of rat brain and liver, and their susceptibility to methylmercury toxicity. Arch Toxicol 2007, 81:769-776.
46. Morken T.S., Sonnewald U., Aschner M., Syversen T. Effects of methylmercury on primary brain cells in mono- and co-culture. Toxicol Sci 2005, 87:169-175.
47. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983, 65:55-63.
48. Onyido I., Norris A.R., Buncel E. Biomolecule-mercury interactions: modalities of DNA base-mercury binding mechanisms. Remediation strategies. Chem Rev 2004, 104:5911-5929.
49. Raha S, Robinson B.H. Mitochondria, oxygen free radicals, disease and ageing. Trends Biochem Sci 2000, 25:502-508.
50. Reznick A.Z., Packer L. Oxidative damage to proteins: spectrophotometric method for carbonyl assay. Methods Enzymol 1994, 233:357-363.
51. Saks V.A., Kuznetsov A.V., Vendelin M., Guerrero K., Kay L., Seppet E.K. Functional coupling as a basic mechanism of feedback regulation of cardiac energy metabolism. Mol Cell Biochem 2004, 256/257:185-199.
52. Sanfeliu C., Sebastia J., Cristofol R., Rodriguez-Farre E. Neurotoxicity of organomercurial compounds. Neurotox Res 2003, 5:283-305.
53. Shanker G., Aschner J.L., Syversen T., Aschner M. Free radical formation in cerebral cortical astrocytes in culture induced by methylmercury. Brain Res Mol Brain Res 2004, 128:48-57.
54. Shenker B.J., Guo T.L., Onyido I., Shapiro I.M. Induction of apoptosis in human T-cells by methyl mercury: temporal relationship between mitochondrial dysfunction and loss of reductive reserve. Toxicol Appl Pharmacol 1999, 157:23-35.
55. Sirois J.E., Atchison W.D. Methylmercury affects multiple subtypes of calcium channels in rat cerebellar granule cells. Toxicol Appl Pharmacol 2000, 167:1-11.
56. Srinivasan U., Mieyal P.A., Mieyal J.J. pH profiles indicative of rate-limiting nucleophilic displacement in thioltransferase catalysis. Biochemistry 1997, 36:3199-3206.
57. Steeghs K., Benders A., Oerlemans F., de Haan A., Heerschap A., Ruitenbeek W., et al. Altered Ca2+ responses in muscles with combined mitochondrial and cytosolic creatine kinase deficiencies. Cell 1997, 89:93-103.
58. Stringari J., Nunes A.K., Franco J.L., Bohrer D., Garcia S.C., Dafre A.L., et al. Prenatal methylmercury exposure hampers glutathione antioxidant system ontogenesis and causes long-lasting oxidative stress in the mouse brain. Toxicol Appl Pharmacol 2008, 227:147-154.
59. Tomimoto H., Yamamoto K., Homburger H.A., Yanagihara T. Immunoelectron microscopic investigation of creatine kinase BB-isoenzyme after cerebral ischemia in gerbils. Acta Neuropathol 1993, 86:447-455.
60. Vieira de Almeida L.M., Pineiro C.C., Leite M.C., Brolese G., Leal R.B., Gottfried C., et al. Protective effects of resveratrol on hydrogen peroxide induced toxicity in primary cortical astrocyte cultures. Neurochem Res 2008, 33:8-15.
61. Vyssokikh M.Y., Brdiczka D. The function of complexes between the outer mitochondrial membrane pore (VDAC) and the adenine nucleotide translocase in regulation of energy metabolism and apoptosis. Acta Biochim Pol 2003, 50:389-404.
62. Wagner C., Vargas A.P., Roos D.H., Morel A.F., Farina M., Nogueira C.W., et al. Comparative study of quercetin and its two glycoside derivatives quercitrin and rutin against methylmercury (MeHg)-induced ROS production in rat brain slices. Arch Toxicol 2009.
63. Wallimann T., Hemmer W. Creatine kinase in non-muscle tissues and cells. Mol Cell Biochem 1994, 133/134:193-220.
64. Wallimann T., Wyss M., Brdiczka D., Nicolay K., Eppenberger H.M. Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the 'phosphocreatine circuit' for cellular energy homeostasis. Biochem J 1992, 281:21-40.
65. Wang P.F., McLeish M.J., Kneen M.M., Lee G., Kenyon G.L. An unusually low pK(a) for Cys282 in the active site of human muscle creatine kinase. Biochemistry 2001, 40:11698-11705.
66. Wegmann G., Zanolla E., Eppenberger H.M., Wallimann T. In situ compartmentation of creatine kinase in intact sarcomeric muscle: the acto-myosin overlap zone as a molecular sieve. J Muscle Res Cell Motil 1992, 13:420-435.
67. Wendt S., Dedeoglu A., Speer O., Wallimann T., Beal M.F., Andreassen O.A. Reduced creatine kinase activity in transgenic amyotrophic lateral sclerosis mice. Free Radical Biol Med 2002, 32:920-926.